Internal Reference Number: FOI_8317
Date Request Received: 28/11/2024 00:00:00
Date Request Replied To: 10/12/2024 00:00:00
This response was sent via: By Email
Request Summary: Coagulase-Negative Staphylococci Data in ICU
Request Category: Students (Educational)
| Question Number 1: I am writing to request information under the Freedom of Information Act 2000. In order to assist you with this request, I am outlining my request as specifically as possible. I would be greatly appreciative if you could provide the following information: Number of blood cultures taken from patients in intensive care units in your Trust that grew coagulase-negative staphylococci (including coagulase-negative staphylococci that were identified to species level) from January 2023 to December 2024. | |
| Answer To Question 1: 20 | |
| Question Number 2: Please confirm whether in your Trust antimicrobial susceptibility testing data is routinely available for all coagulase-negative staphylococcal blood culture isolates or only for those deemed to be a cause of infection. | |
| Answer To Question 2: Direct sensitivities are carried out on all isolates but EUCAST sensitivities are only carried out and released if considered to be a cause of bloodstream infection. | |
| Question Number 3: If antimicrobial susceptibility testing data is available for all coagulase-negative staphylococcal blood culture isolates, please indicate how far back in time and for what time period is the antimicrobial susceptibility testing data available. | |
| Answer To Question 3: Antimicrobial susceptibility testing data is held on the LIMS so goes back to when the LIMS was introduced, unsure when but > 10years | |
| Question Number 4: Please confirm the antimicrobial susceptibility testing method used in your Trust, e.g. disc diffusion, Vitek 2, and whether EUCAST or CLSI interpretative criteria are used. | |
| Answer To Question 4: EUCAST disc diffusion | |
| Question Number 5: Please confirm whether coagulase-negative staphylococcal blood culture isolates in your Trust are routinely retained in the laboratory, e.g. on beads or on slopes. | |
| Answer To Question 5: On beads for 1 year if clinically significant | |
| Question Number 6: If yes to Question 5, indicate how far back in time and for what time period coagulase-negative staphylococcal blood culture isolates are available. Please indicate if only select isolates are available, for example, those considered to be a cause of bloodstream infection. | |
| Answer To Question 6: On beads for 1 year if clinically significant | |
| Question Number 7: Does your Trust use whole-body skin bacterial decontamination for all or selected patients? | |
| Answer To Question 7: Selected patients | |
| Question Number 8: With respect to whole-body skin decontamination, please confirm to which hospital patient groups this is administered, e.g. all admissions, only high-impact acute specialities, only MRSA-positive patient. Please provide the relevant Trust policy/guideline. | |
| Answer To Question 8: MRSA positive, pre orthopaedic joint arthroplasty and complex spinal operations | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
